Drugs / NRT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03199807 | Jul 2017 → Jul 2020 | hepatocellular carcinoma | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NRT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03199807 ↗ |
| Modality | Cell therapy | “Peripheral blood lymphocytes will be collected and neoantigen reactive T cells(NRTs) will be generated in the laboratory.” NCT03199807 ↗ |
| Route | Intravenous | “will be i.v.” NCT03199807 ↗ |